Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Venaxis Inc (APPY)

Venaxis Inc (APPY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Venaxis Inc 1775 38TH STREET BOULDER CO 80301

www.venaxis.com P: 303-545-5550

Description:

Venaxis, Inc. is a biomedical diagnostic company focused on the clinical development and commercialization of its blood-based appendicitis test, APPY1. APPY1 is being developed initially for pediatric, adolescent and young adult patients with abdominal pain. Venaxis, Inc., formerly known as AspenBio Pharma, Inc., is based in Castle Rock, Colorado.

Key Statistics

Overview:

Market Capitalization, $K 17,790
Shares Outstanding, K 4,500
Annual Sales, $ 200 K
Annual Net Income, $ -8,760 K
Last Quarter Sales, $ 30 K
Last Quarter Net Income, $ -1,710 K
60-Month Beta 2.56
% of Insider Shareholders 8.60%
% of Institutional Shareholders 7.42%

Growth:

1-Year Return 53.91%
3-Year Return -72.79%
5-Year Return -91.74%
5-Year Revenue Growth -54.55%
5-Year Earnings Growth -97.25%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 11/22/16
Earnings Per Share ttm -1.72
EPS Growth vs. Prev Qtr -95.45%
EPS Growth vs. Prev Year -7.50%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-8 on 03/31/16

APPY Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -41.70%
Return-on-Assets % -36.00%
Profit Margin % -4,380.00%
Debt/Equity 0.00
Price/Sales 176.15
Price/Cash Flow N/A
Price/Book 1.04
Book Value/Share 3.79
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar